4131.TWO · NEOCORE
Taiwan · RS rating 35 · As of 2026-10-08
| Price | 31.20 TWD |
|---|---|
| 1-day change | +1.6% |
| RS rating (overall / 1M / 3M / 12M) | 35 / 62 / 44 / 46 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 32 / 18 / 12 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +58.2% |
| Distance from 52-week high | +25.7% |
| Market cap (USD) | $38.4M |